Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Perrone

Showing results (41-50 of 160) with videos related to

Pageof 16
Sort By:
World Journal of Gastrointestinal Oncology|December 17, 2010
Experience with peritoneal mesothelioma at the Milan National Cancer InstituteMarcello Deraco, Dario Baratti, Antonello Domenico Cabras, et al.
Oncology|May 22, 2019
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor AgentsStefano Cavalieri, Federica Perrone, Massimo Milione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
A Prospective Observational Study of Active Surveillance in Primary Desmoid FibromatosisChiara Colombo, Marco Fiore, Giovanni Grignani, et al.
Expert Opinion on Investigational Drugs|March 23, 2019
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?Stefano Cavalieri, Francesca Platini, Cristiana Bergamini, et al.
Tumori|August 18, 2018
Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center studyStefano Signoroni, Maria Grazia Tibiletti, Maria Teresa Ricci, et al.
Cancer Treatment Reviews|November 27, 2018
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectivesFrancesca Corti, Federico Nichetti, Alessandra Raimondi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2015
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II studyMaria Di Bartolomeo, Andrea Ciarlo, Alessandro Bertolini, et al.
Cancer Medicine|April 11, 2016
AKT1 and BRAF mutations in pediatric aggressive fibromatosisCristina Meazza, Antonino Belfiore, Adele Busico, et al.
Tumori|May 2, 2018
Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancersCarlo Resteghini, Federica Perrone, Rosalba Miceli, et al.
Oncotarget|February 13, 2016
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinomaEmanuela Minna, Paola Romeo, Matteo Dugo, et al.
Pageof 16

Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
World Journal of Gastrointestinal Oncology|December 17, 2010
Experience with peritoneal mesothelioma at the Milan National Cancer InstituteMarcello Deraco, Dario Baratti, Antonello Domenico Cabras, et al.
Oncology|May 22, 2019
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor AgentsStefano Cavalieri, Federica Perrone, Massimo Milione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
A Prospective Observational Study of Active Surveillance in Primary Desmoid FibromatosisChiara Colombo, Marco Fiore, Giovanni Grignani, et al.
Expert Opinion on Investigational Drugs|March 23, 2019
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?Stefano Cavalieri, Francesca Platini, Cristiana Bergamini, et al.
Tumori|August 18, 2018
Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center studyStefano Signoroni, Maria Grazia Tibiletti, Maria Teresa Ricci, et al.
Cancer Treatment Reviews|November 27, 2018
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectivesFrancesca Corti, Federico Nichetti, Alessandra Raimondi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2015
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II studyMaria Di Bartolomeo, Andrea Ciarlo, Alessandro Bertolini, et al.
Cancer Medicine|April 11, 2016
AKT1 and BRAF mutations in pediatric aggressive fibromatosisCristina Meazza, Antonino Belfiore, Adele Busico, et al.
Tumori|May 2, 2018
Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancersCarlo Resteghini, Federica Perrone, Rosalba Miceli, et al.
Oncotarget|February 13, 2016
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinomaEmanuela Minna, Paola Romeo, Matteo Dugo, et al.
Pageof 16